Literature DB >> 20006135

Definition of epitopes and antigens recognized by vaccinia specific immune responses: their conservation in variola virus sequences, and use as a model system to study complex pathogens.

Alessandro Sette1, Howard Grey, Carla Oseroff, Bjoern Peters, Magdalini Moutaftsi, Shane Crotty, Erika Assarsson, Jay Greenbaum, Yohan Kim, Ravi Kolla, David Tscharke, David Koelle, R Paul Johnson, Janice Blum, Steven Head, John Sidney.   

Abstract

In the last few years, a wealth of information has become available relating to the targets of vaccinia virus (VACV)-specific CD4(+) T cell, CD8(+) T cell and antibody responses. Due to the large size of its genome, encoding more than 200 different proteins, VACV represents a useful model system to study immunity to complex pathogens. Our data demonstrate that both cellular and humoral responses target a large number of antigens and epitopes. This broad spectrum of targets is detected in both mice and humans. CD4(+) T cell responses target late and structural antigens, while CD8(+) T cells preferentially recognize early antigens. While both CD4(+) and CD8(+) T cell responses target different types of antigens, the antigens recognized by T(H) cells are highly correlated with those recognized by antibody responses. We further show that protein abundance and antibody recognition can be used to predict antigens recognized by CD4(+) T cell responses, while early expression at the mRNA level predicts antigens targeted by CD8(+) T cells. Finally, we find that the vast majority of VACV epitopes are conserved in variola virus (VARV), thus suggesting that the epitopes defined herein also have relevance for the efficacy of VACV as a smallpox vaccine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20006135      PMCID: PMC2928716          DOI: 10.1016/j.vaccine.2009.10.011

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  21 in total

Review 1.  Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses.

Authors:  Jonathan W Yewdell
Journal:  Immunity       Date:  2006-10       Impact factor: 31.745

2.  Protein composition of the vaccinia virus mature virion.

Authors:  Wolfgang Resch; Kim K Hixson; Ronald J Moore; Mary S Lipton; Bernard Moss
Journal:  Virology       Date:  2006-09-26       Impact factor: 3.616

3.  Using HLA-transgenic mice to identify immunodominant human CD8+ T cell epitopes--does (genome) size matter?

Authors:  Masanori Terajima; Francis A Ennis
Journal:  Immunol Lett       Date:  2006-02-17       Impact factor: 3.685

4.  Poxvirus CD8+ T-cell determinants and cross-reactivity in BALB/c mice.

Authors:  David C Tscharke; Wai-Ping Woo; Isaac G Sakala; John Sidney; Alessandro Sette; Denis J Moss; Jack R Bennink; Gunasegaran Karupiah; Jonathan W Yewdell
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

5.  HLA-A*0201, HLA-A*1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products.

Authors:  Valerie Pasquetto; Huynh-Hoa Bui; Rielle Giannino; Cindy Banh; Fareed Mirza; John Sidney; Carla Oseroff; David C Tscharke; Kari Irvine; Jack R Bennink; Bjoern Peters; Scott Southwood; Vincenzo Cerundolo; Howard Grey; Jonathan W Yewdell; Alessandro Sette
Journal:  J Immunol       Date:  2005-10-15       Impact factor: 5.422

6.  HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation.

Authors:  Carla Oseroff; Ferdynand Kos; Huynh-Hoa Bui; Bjoern Peters; Valerie Pasquetto; Jean Glenn; Tara Palmore; John Sidney; David C Tscharke; Jack R Bennink; Scott Southwood; Howard M Grey; Jonathan W Yewdell; Alessandro Sette
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-19       Impact factor: 11.205

7.  A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus.

Authors:  Magdalini Moutaftsi; Bjoern Peters; Valerie Pasquetto; David C Tscharke; John Sidney; Huynh-Hoa Bui; Howard Grey; Alessandro Sette
Journal:  Nat Biotechnol       Date:  2006-06-11       Impact factor: 54.908

8.  Dominance and diversity in the primary human CD4 T cell response to replication-competent vaccinia virus.

Authors:  Lichen Jing; Tiana M Chong; Benjamin Byrd; Christopher L McClurkan; Jay Huang; Brian T Story; Karissa M Dunkley; Lydia Aldaz-Carroll; Roselyn J Eisenberg; Gary H Cohen; William W Kwok; Allesandro Sette; David M Koelle
Journal:  J Immunol       Date:  2007-05-15       Impact factor: 5.422

9.  Vaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles.

Authors:  Che-Sheng Chung; Chein-Hung Chen; Ming-Yi Ho; Cheng-Yen Huang; Chung-Lin Liao; Wen Chang
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

10.  Pox proteomics: mass spectrometry analysis and identification of Vaccinia virion proteins.

Authors:  Jennifer D Yoder; Tsefang S Chen; Cliff R Gagnier; Srilakshmi Vemulapalli; Claudia S Maier; Dennis E Hruby
Journal:  Virol J       Date:  2006-03-01       Impact factor: 4.099

View more
  25 in total

1.  Immunization with a ZmpB-based protein vaccine could protect against pneumococcal diseases in mice.

Authors:  Yi Gong; Wenchun Xu; Yali Cui; Xuemei Zhang; Run Yao; Dairong Li; Hong Wang; Yujuan He; Ju Cao; Yibing Yin
Journal:  Infect Immun       Date:  2010-11-22       Impact factor: 3.441

Review 2.  Enhancing poxvirus vectors vaccine immunogenicity.

Authors:  Juan García-Arriaza; Mariano Esteban
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

3.  T cell antigen discovery using soluble vaccinia proteome reveals recognition of antigens with both virion and nonvirion association.

Authors:  D Huw Davies; Sookhee Chun; Gary Hermanson; Jo Anne Tucker; Aarti Jain; Rie Nakajima; Jozelyn Pablo; Philip L Felgner; Xiaowu Liang
Journal:  J Immunol       Date:  2014-07-14       Impact factor: 5.422

Review 4.  Smallpox vaccines: targets of protective immunity.

Authors:  Bernard Moss
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

5.  The identification of HLA class II-restricted T cell epitopes to vaccinia virus membrane proteins.

Authors:  Richard B Kennedy; Gregory A Poland
Journal:  Virology       Date:  2010-10-18       Impact factor: 3.616

6.  Identification of T-cell epitopes in Francisella tularensis using an ordered protein array of serological targets.

Authors:  Michael D Valentino; Zachary J Maben; Lucinda L Hensley; Matthew D Woolard; Thomas H Kawula; Jeffrey A Frelinger; John G Frelinger
Journal:  Immunology       Date:  2011-01-07       Impact factor: 7.397

7.  CD4 T-cell memory responses to viral infections of humans show pronounced immunodominance independent of duration or viral persistence.

Authors:  Lichen Jing; Joshua T Schiffer; Tiana M Chong; Joseph J Bruckner; D Huw Davies; Phillip L Felgner; Juergen Haas; Anna Wald; G M G M Verjans; David M Koelle
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

8.  Poor Antigen Processing of Poxvirus Particles Limits CD4+ T Cell Recognition and Impacts Immunogenicity of the Inactivated Vaccine.

Authors:  Katherine S Forsyth; Brian DeHaven; Mark Mendonca; Sinu Paul; Alessandro Sette; Laurence C Eisenlohr
Journal:  J Immunol       Date:  2019-01-30       Impact factor: 5.422

9.  Identification and Characterization of CD4+ T Cell Epitopes after Shingrix Vaccination.

Authors:  Alessandro Sette; Alba Grifoni; Hannah Voic; Rory D de Vries; John Sidney; Paul Rubiro; Erin Moore; Elizabeth Phillips; Simon Mallal; Brittany Schwan; Daniela Weiskopf
Journal:  J Virol       Date:  2020-11-23       Impact factor: 5.103

10.  Expression and cellular immunogenicity of a transgenic antigen driven by endogenous poxviral early promoters at their authentic loci in MVA.

Authors:  Toritse Orubu; Naif Khalaf Alharbi; Teresa Lambe; Sarah C Gilbert; Matthew G Cottingham
Journal:  PLoS One       Date:  2012-06-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.